| Literature DB >> 35313534 |
Tilman Engel1, Anne Schraplau1, Monique Wochatz1, Stephan Kopinski1, Dominik Sonnenburg1, Anne Schomoeller1, Lucie Risch1, Hannes Kaplick1, Frank Mayer1.
Abstract
Eccentric exercise is discussed as a treatment option for clinical populations, but specific responses in terms of muscle damage and systemic inflammation after repeated loading of large muscle groups have not been conclusively characterized. Therefore, this study tested the feasibility of an isokinetic protocol for repeated maximum eccentric loading of the trunk muscles. Nine asymptomatic participants (5 f/4 m; 34±6 yrs; 175±13 cm; 76±17 kg) performed three isokinetic 2-minute all-out trunk strength tests (1x concentric (CON), 2x eccentric (ECC1, ECC2), 2 weeks apart; flexion/extension, 60°/s, ROM 55°). Outcomes were peak torque, torque decline, total work, and indicators of muscle damage and inflammation (over 168 h). Statistics were done using the Friedman test (Dunn's post-test). For ECC1 and ECC2, peak torque and total work were increased and torque decline reduced compared to CON. Repeated ECC bouts yielded unaltered torque and work outcomes. Muscle damage markers were highest after ECC1 (soreness 48 h, creatine kinase 72 h; p<0.05). Their overall responses (area under the curve) were abolished post-ECC2 compared to post-ECC1 (p<0.05). Interleukin-6 was higher post-ECC1 than CON, and attenuated post-ECC2 (p>0.05). Interleukin-10 and tumor necrosis factor-α were not detectable. All markers showed high inter-individual variability. The protocol was feasible to induce muscle damage indicators after exercising a large muscle group, but the pilot results indicated only weak systemic inflammatory responses in asymptomatic adults. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).Entities:
Keywords: eccentric,; exercise induced muscle damage,; exercise,; inflammation,; interleukin-6,; internleukin-10,; isokinetics,; muscle fatigue,; repeated bout effect,; trunk muscles,; tumor necrosis factor-α
Year: 2022 PMID: 35313534 PMCID: PMC8934203 DOI: 10.1055/a-1757-6724
Source DB: PubMed Journal: Sports Med Int Open ISSN: 2367-1890
Table 1 Anthropometric data of participants.
|
| Age [years] | Weight [kg] | Height [m] | Phys. Activity [h/week]* | |
|---|---|---|---|---|---|
|
| 9 | 34±6 | 76±17 | 1.75±0.13 | 2.1±1.9 |
|
| 5 | 35±7 | 64±13 | 1.65±0.07 | 2.8±2.1 |
|
| 4 | 32±5 | 90±6 | 1.87±0.08 | 1.2±1.4 |
Data is presented as mean±SD ; *Physical activity: hours of sport within 7 days before first measurement day.
Fig. 1Measurement procedures with isokinetic trunk strength protocols and time points of assessed outcomes. a ) General testing protocol including all three time points of measurement. b ) Isokinetic testing conditions and exemplary participant within the isokinetic dynamometer. c ) Time points of outcome assessments before and after isokinetic testing. CON, 2-minute concentric protocol; ECC1 and ECC2, 2-minute eccentric protocols; MVC, maximum voluntary contraction; MS, muscle soreness; RPE, rating of perceived exertion; VBS, venous blood sampling; CBS, capillary blood sampling; post, immediately after exercise protocol; 4 h–168 h hours after exercise protocol.
Table 2 Peak torque, total work, blood lactate, and RPE for the maximal concentric and repeated maximal eccentric loading of the trunk.
| Movement direction | Peak torque [Nm] | Work [J] | Blood Lactate [mmol/l] | RPE [Score] | ||||
|---|---|---|---|---|---|---|---|---|
| Begin | Mid | End | Begin to End | pre | post | post | ||
|
| Extension | 272±114 | 218±85 | 187±71 | 7279±2853 | 0.9±0.4 | 6.9±2.3 | 18.9±1.2 |
| Flexion | 156±68 | 116±50 | 93±34 | 4273±1920 | ||||
|
| Extension | 189±93 # | 161±83 | 142±72 | 5707±3254 # | 1.0±0.3 | 4.9±2.3 # | 18.8±1.3 |
| Flexion | 331±147 | 293±141 | 265±120 | 10369±4638 # | ||||
|
| Extension | 186±94 # | 154±86 | 140±74 | 5368±3154 | 0.9±0.3 | 4.8±2.3 # | 18.7±1.1 |
| Flexion | 309±130 | 270±107 | 239±87 | 9311±3487 # | ||||
Data are presented as mean±SD for N=9. CON, 2-minute concentric protocol; ECC1, ECC2, 2-minute eccentric protocol; RPE, ratings of perceived exertion. Statistically significant differences (p<0.05) for CON vs. ECC1 or CON vs. ECC2 are indicated by (#); Friedman test with Dunn’s multiple comparisons test.
Fig. 2Trunk extensor and flexor peak torque during the 2-minute all-out protocols. CON, 2-minute concentric protocol (solid line); ECC1 and ECC2, 2-minute eccentric protocol (dotted line and dash-dotted line); Begin, beginning; Mid, midpoint; End, endpoint. a–c) Individual courses of trunk extensor peak torque for each participant. e–g ) Individual courses of trunk flexor peak torque. d , h ) Mean peak torque courses with differences relative to Begin.
Fig. 3Changes in markers of muscle damage and inflammation after the 2-minute all-out protocols. a ) Perceived muscle soreness was assessed using a Numeric Rating Scale (NRS 0–10). Concentrations of muscle enzymes ( b–d ) and inflammatory parameters ( e , f ) were assessed in serum samples. Data is presented as mean±SD for N=7 (A) and N=7–9 (B-F). CON, 2-minute concentric protocol; ECC1, ECC2, 2-minute eccentric protocol. Note the logarithmic scale on the y axis of graph B.
Table 3 Changes in markers of muscle damage and inflammation over 72 h after the 2-minute all-out protocols. Markers of muscle damage and inflammation were assessed before and at different time points after each exercise bout. Peak time after ECC1 was selected (according to Fig. 3 ) and values of each parameter at this time point after CON, ECC1, and ECC2 were statistically analyzed. Area under the curve (AUC) was calculated for the period of pre- (0 h) to 72 h post-exercise.
| CON | ECC1 | ECC2 | |
|---|---|---|---|
|
| |||
| [NRS] at peak (48 h post) | 1.1±1.3 | 4.9±2.9 #,$ | 1.3±1.1 |
| AUC [NRS*72 h] | 82±61 | 226±143 #,$ | 87±73 |
|
| |||
| [U/l] at peak (72 h post) | 356.9±657.5 | 15998.9±20520.2 #,$ | 408.7±692.5 |
| AUC [U/l*72 h] | 16651±14282 | 595084±808004 $ | 15764±16472 |
|
| |||
| [U/l] at peak (72 h post) | 22.4±5.1 | 190.9±240.3 # | 22.8±6.6 |
| AUC [U/l*72 h] | 1580±416 | 7513±8371 | 1566±265 |
|
| |||
| [U/l] at peak (72 h post) | 23.0±10.2 | 66.4±68.1 | 24.0±7.6 |
| AUC [U/l*72 h] | 1552±705 | 2803±1901 | 1788±579 |
|
| |||
| [U/l] at peak (72 h post) | 0.6±0.8 | 1.2±1.9 | 0.4±0.4 |
| AUC [U/l*72 h] | 78±105 | 42±40 | 35±29 |
|
| |||
| [pg/ml] at peak (72 h post) | 0.4±0.4 | 1.0±0.9 | 0.7±0.3 |
| AUC [pg/ml*72 h] | 33±32 | 58±39 | 43±25 |
|
| |||
| [pg/ml] | n.d. | n.d. | n.d. |
|
| |||
| [pg/ml] | n.d. | n.d. | n.d. |
Data are presented as mean±SD for N=7 (muscle soreness) or N=9. CON, 2-minute concentric protocol; ECC1, ECC2, 2-minute eccentric protocol; n.d., not detectable (high sensitivity ELISA, limit of detection (LoD) (TNF-α)=0.13 pg/ml; LoD (IL-10)=0.05 pg/ml). Statistically significant differences (p<0.05) are indicated by (#) for CON vs. ECC1 and ($) for ECC1 vs. ECC2; Friedman test with Dunn’s multiple comparisons test.